Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: Secondary analysis of a randomized controlled trial

Rheumatology (United Kingdom)

Volumn 55, Issue 2, 2015, Pages 268-278

  Matcham, Faith ^a   Norton, Sam ^b   Scott, David L ^c   Steer, Sophia ^c   Hotopf, Matthew ^a  

^a Department of Psychological Medicine ^*  (United Kingdom)

^b Psychology Department   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anxiety; Depression; Disease activity; HAQ; Joint erosion; Longitudinal; Pain; Remission; Rheumatoid arthritis (RA)

Indexed keywords

CYCLOSPORIN; METHOTREXATE; PREDNISOLONE; ANTIRHEUMATIC AGENT; GLUCOCORTICOID;

ADULT; ANXIETY; ARTHRALGIA; ARTICLE; DEPRESSION; DISEASE ACTIVITY; DRUG DOSE INCREASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ASSESSMENT; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RHEUMATOID ARTHRITIS; SECONDARY ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPLICATION; CONTROLLED STUDY; FOLLOW UP; HEALTH STATUS; MULTICENTER STUDY; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ANTIRHEUMATIC AGENTS; ANXIETY; ARTHRITIS, RHEUMATOID; DEPRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84961970588     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev306     Document Type: Article

References (36)

1. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 2013;52:2136-48.
2. Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 2004;49:124-38.
3. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
4. Rayner L, Matcham F, Hutton J et al. Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatry 2014;36:318-24.
5. Norton S, Sacker A, Young A, Done J. Distinct psychological distress trajectories in rheumatoid arthritis: findings from an inception cohort. J Psychosom Res 2011;71:290-5.
6. Kojima M, Kojima T, Suzuki S et al. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Care Res 2009;61:1018-24.
7. Matcham F, Ali S, Hotopf M, Chalder T. Psychological correlates of fatigue in rheumatoid arthritis: A systematic review. Clin Psychol Rev 2015;39:16-29.
8. Mikuls T, Saag K, Criswell L, Merlino L, Cerhan JR. Health related quality of life in women with elderly onset rheumatoid arthritis. J Rheumatol 2003;30:952-7.
9. Joyce AT, Smith P, Khandker R, Melin JM, Singh A. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 2009;36:743-52.
10. Overman CL, Bossema ER, van Middendorp H et al. The prospective association between psychological distress and disease activity in rheumatoid arthritis: a multilevel regression analysis. Ann Rheum Dis 2012;71:192-7.
11. Karpouzas G, Dolatabadi S, Moran R et al. Correlates and predictors of disability in vulnerable US Hispanics with rheumatoid arthritis. Arthritis Care Res 2012;64:1274-81.
12. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 2005;32:1013-9.
13. Sheehy C, Murphy E, Barry M. Depression in rheumatoid arthritis _ underscoring the problem. Rheumatology 2006;45:1325-7.
14. McAllister-Williams RH, Ferrier IN, Young AH. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychol Med 1998;28:573-84.
15. Gold PW Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: relations to the neurobiology of stress. New Eng J Med 1988;319:348-53.
16. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003;139:359-70
17. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. The Lancet 2009;373:1905-17.
18. DiMatteo M, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment:meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
19. Baumeister H, Balke K, Härter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 2005;58:1090-100.
20. Fichna J, Janecka A, Costentin J, Do Rego JC. The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 2007;59:88-123.
21. Rathburn AM, Reed GW, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology 2013;52:1785-94.
22. Choy EHS, Smith CM, Farewell V et al. Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis 2008;67:656-63.
23. Spitzer RL, Williams JB, Kroenke K et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-56.
24. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology 1997;36:551-9.
25. National Collaborating Centre for Mental Health. Depression in adults with a chronic physical health problem:treatment and management. NICE Clinical Guidance 91 London: National Institute for Health and Clinical Excellence, 2009.
26. Fries JF, Spitz P, Kraines GR, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
27. National Institute for Health and Care Excellence (NICE). Rheumatoid arthritis: the management of rheumatoid arthritis in adults. http://publications.nice.org.uk/ rheumatoid-arthritis-cg79. Accessed 2 July 2013.
28. Kalyoncu U, Dougados M, Daures J-P, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009;68:183-90.
29. Fransen J, van Riel PL. DAS remission cut points. Clin Exp Rheumatol 2006;24:S29_32.
30. Farmer DF, Jackson SA, Camacho F, Hall MA. Attitudes of African American and low socioeconomic status white women towards medical research. J Health Care Poor Underserved 2007;18:85-99.
31. Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005;64:1588-94.
32. Miech RA, Caspi A, Moffitt TE, Wright BRE, Silva PA. Low socioeconomic status and mental disorders: a longitudinal study of selection and causation during young adulthood. Am J Sociol 1999;104:1096-131.
33. Jacobi CE, Mol GD, Boshuizen HC et al. Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arth Care Res 2003;49:567-73.
34. Rayner L, Price A, Evans A et al. Antidepressants for depression in physically ill people. Cochrane DB Syst Rev 2010;(3):CD007503.
35. Matcham F, Rayner L, Hutton J et al. Self-help interventions for symptoms of depression, anxiety and psychological distress in patients with physical illness: a systematic review and meta-analysis. Clin Psychol Rev 2014;34:141-57.
36. Katon WJ, Lin EHB, Von Korff M et al. Collaborative care for patients with depression in chronic illnesses. New Eng J Med 2010;363:2611-20.